Effectiveness of BNT162b2 COVID-19 vaccination in prevention of hospitalisations and severe disease in adults with SARS-CoV-2 Delta (B.1.617.2) and Omicron (B.1.1.529) variant between June 2021 and July 2022: A prospective test negative case-control study. (2023)

First Author: Chatzilena A
Attributed to:  Uncertainty Quantification for Expensive COVID-19 Simulation Models (UQ4Covid) funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.lanepe.2022.100552

PubMed Identifier: 36506791

Publication URI: http://europepmc.org/abstract/MED/36506791

Type: Journal Article/Review

Volume: 25

Parent Publication: The Lancet regional health. Europe

ISSN: 2666-7762